Stock MARKSANS MARKSANS PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Marksans Pharma Limited Bombay S.E.

Equities

MARKSANS

INE750C01026

Market Closed - Bombay S.E.
Other stock markets
 00:10:38 2024-04-29 EDT 		5-day change 1st Jan Change
171 INR -0.67% Intraday chart for Marksans Pharma Limited +1.88% +6.31%
04-18 Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA MT
02-14 Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA
MT
Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024
Marksans Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Transcript : Marksans Pharma Limited, Q2 2024 Earnings Call, Nov 09, 2023
Marksans Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Marksans Pharma Arm Gets UK Regulator's Approval to Market Cyanocobalamin Tablets
MT
Marksans Pharma Undergoes Successful Inspection from German Health Authorities
MT
CARE Affirms A+ Rating on Marksans Pharma's Long-term Bank Financing; Outlook Stable
MT
Marksans Pharma Gets US FDA Nod for Esomeprazole Magnesium Delayed-Release Capsules
MT
Marksans Pharma Limited Announces US FDA Approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg
CI
Marksans Pharma Limited Approves Payment of Dividend
CI
Marksans Pharma Limited Appoints Shailaja Vardhan as an Independent Director
CI
Marksans Pharma Gets US FDA's Final Approval for Generic Cough Medicine
MT
Marksans Pharma Ltd. Receives USFDA Approval for Guaifenesin Extended-Release Tablets
CI
Transcript : Marksans Pharma Limited, Q1 2024 Earnings Call, Aug 16, 2023
Marksans Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Marksans Pharma Limited Recommends Payment of Dividend for the Financial Year 2022-23
CI
Marksans Pharma's Goa Plant Gets Two Observations from US FDA
MT
Marksans Pharma Gets US FDA Nod for Pain Relief Drug
MT
Marksans Pharma Limited Announces That It Has Received Final Approval from the Us Food and Drug Administration for Its Abbreviated New Drug Application for Acetaminophen and Ibuprofen Tablets, 250 Mg/125 Mg
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MARKSANS Stock
  4. MARKSANS Stock
  5. News Marksans Pharma Limited